stellar-303: xl092 with atezolizumab or regorafenib in patients with mcrc
Published 1 year ago • 404 plays • Length 2:32Download video MP4
Download video MP3
Similar videos
-
2:14
stellar-303: xl092 with atezolizumab compared to regorafenib in patients with mcrc
-
5:30
rationale and design of stellar-303: zanzalintinib atezolizumab vs regorafenib in mss/msi-low mcrc
-
2:30
stellar-303: xl092, a novel tki, in pre-treated, mms/msi-low colorectal cancer
-
3:18
a dose-escalation study of regorafenib in mcrc
-
1:23
the rationale for combining regorafenib with io to treat patients with refractory mss-crc
-
4:07
80mg regorafenib plus pembrolizumab for 1l hcc
-
2:42
paradigm: panitumumab versus bevacizumab in ras-wt mcrc
-
1:45
las vegas man is first patient in new clinical cancer trial
-
3:03
quest1 clinical trial updates
-
1:16
24 month os results of the scandium trial
-
4:10
lenz: stivarga (regorafenib) treatment, dosing strategies
-
1:30
real-time immune cell killing of 3d tumor spheroid assays using xcelligence rtca esight
-
7:34
escrs 2016 excimercentrposmoderatedrevv-16287
-
2:14
where do the umbilical cord stem cells come from? 1 (844) get-stem
-
1:39
tribbles homolog 2: at the center of tumorigenesis and stem cell fate
-
0:29
ht-x1 - multi-well imaging
-
1:25
neoadjuvant immunotherapy in msi-high colorectal cancer
-
3:03
elipse clinical trial